
Check-Cap Ltd. CHEK
Annual report 2024
added 04-11-2026
Check-Cap Ltd. EV - Enterprise Value 2011-2026 | CHEK
Annual EV - Enterprise Value Check-Cap Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 2.55 M | -5.6 M | 7.33 M | 7.79 B | 12.6 B | 24 M | 17.7 M | 4.48 M | -791 K | 3.37 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.6 B | -5.6 M | 2.04 B |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
45.8 B | $ 117.31 | 1.94 % | $ 35.7 B | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 16.76 | 4.39 % | $ 893 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 2.2 | -4.35 % | $ 9.73 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 1.44 | 5.11 % | $ 1.92 M | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 23.52 | 1.69 % | $ 653 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 177.53 | 1.05 % | $ 8.8 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
14 B | $ 498.33 | 0.97 % | $ 14.4 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.6 | 5.63 % | $ 426 M | ||
|
Danaher Corporation
DHR
|
145 B | $ 195.23 | 2.99 % | $ 139 B | ||
|
NeoGenomics
NEO
|
1.85 B | $ 7.96 | 3.51 % | $ 1.02 B | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
15.3 B | $ 126.4 | 4.52 % | $ 20.1 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 15.33 | 6.2 % | $ 464 M | ||
|
Guardant Health
GH
|
15.2 B | $ 81.93 | 4.24 % | $ 10.3 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 6.69 | 0.15 % | $ 279 M | ||
|
Anixa Biosciences
ANIX
|
990 K | $ 2.84 | 5.58 % | $ 92.2 K | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.09 | -1.88 % | $ 4.8 M | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 28.55 | 0.87 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 109.57 | 2.58 % | $ 9.04 B | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | $ 52.66 | 0.05 % | $ 2.68 B | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 264.34 | 1.31 % | $ 22 B | ||
|
Natera
NTRA
|
5.53 B | $ 200.92 | 4.08 % | $ 19.8 B | ||
|
Celcuity
CELC
|
5.57 B | $ 119.65 | 2.14 % | $ 5.59 B | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 81.32 | 0.91 % | $ 5.49 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Neuronetics
STIM
|
168 M | $ 1.39 | 2.59 % | $ 91.7 M | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 191.77 | 0.13 % | $ 21.3 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.34 | -0.9 % | $ 2.03 B | ||
|
ENDRA Life Sciences
NDRA
|
4.49 M | $ 5.19 | 5.06 % | $ 4.08 M | ||
|
Organovo Holdings
ONVO
|
-4.05 M | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
10.3 M | - | -16.95 % | $ 1.54 M |